Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker

Figure 3

(a, b) Survival analysis of B4GALNT1 expression using Kaplan-Meier DFI curves in CHOL and THCA. (c–p)Survival analysis of B4GALNT1 expression using Kaplan-Meier DSS curves in ACC, BLCA, CHOL, COAD, HNSC, KICH, KIRP, LGG, LUAD, MESO, OV, THYM, UCEC, and UVM.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)